Thrombospondin-2 as a potential noninvasive biomarker of hepatocyte injury but not liver fibrosis in children with MAFLD: A preliminary study

AMA Zdanowicz K, Flisiak-Jackiewicz M, Bobrus-Chociej A, et al. Thrombospondin-2 as a potential noninvasive biomarker of hepatocyte injury but not liver fibrosis in children with MAFLD: A preliminary study. Clinical and Experimental Hepatology - Manuscripts Accepted. 2023. doi:10.5114/ceh.2023.133108. APA Zdanowicz, K., Flisiak-Jackiewicz, M., Bobrus-Chociej, A., Kowalczuk-Kryston, M., Jamiolkowski, J., & Martonik, D. et al. (2023). Thrombospondin-2 as a potential noninvasive biomarker of hepatocyte injury but not liver fibrosis in children with MAFLD: A preliminary study. Clinical and Experimental Hepatology - Manuscripts Accepted. https://doi.org/10.5114/ceh.2023.133108 Chicago Zdanowicz, Katarzyna, Marta Flisiak-Jackiewicz, Anna Bobrus-Chociej, Monika Kowalczuk-Kryston, Jacek Jamiolkowski, Diana Martonik, and Magdalena Rogalska et al. 2023. "Thrombospondin-2 as a potential noninvasive biomarker of hepatocyte injury but not liver fibrosis in children with MAFLD: A preliminary study". Clinical and Experimental Hepatology - Manuscripts Accepted. doi:10.5114/ceh.2023.133108. Harvard Zdanowicz, K., Flisiak-Jackiewicz, M., Bobrus-Chociej, A., Kowalczuk-Kryston, M., Jamiolkowski, J., Martonik, D., Rogalska, M., and Lebensztejn, D. (2023). Thrombospondin-2 as a potential noninvasive biomarker of hepatocyte injury but not liver fibrosis in children with MAFLD: A preliminary study. Clinical and Experimental Hepatology - Manuscripts Accepted. https://doi.org/10.5114/ceh.2023.133108 MLA Zdanowicz, Katarzyna et al. "Thrombospondin-2 as a potential noninvasive biomarker of hepatocyte injury but not liver fibrosis in children with MAFLD: A preliminary study." Clinical and Experimental Hepatology - Manuscripts Accepted, 2023. doi:10.5114/ceh.2023.133108. Vancouver Zdanowicz K, Flisiak-Jackiewicz M, Bobrus-Chociej A, Kowalczuk-Kryston M, Jamiolkowski J, Martonik D et al. Thrombospondin-2 as a potential noninvasive biomarker of hepatocyte injury but not liver fibrosis in children with MAFLD: A preliminary study. Clinical and Experimental Hepatology - Manuscripts Accepted. 2023. doi:10.5114/ceh.2023.133108.